248 related articles for article (PubMed ID: 17164372)
21. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
Walzer M; Bekersky I; Blum RA; Tolbert D
Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
[TBL] [Abstract][Full Text] [Related]
22. Development of the "Inje cocktail" for high-throughput evaluation of five human cytochrome P450 isoforms in vivo.
Ryu JY; Song IS; Sunwoo YE; Shon JH; Liu KH; Cha IJ; Shin JG
Clin Pharmacol Ther; 2007 Nov; 82(5):531-40. PubMed ID: 17392720
[TBL] [Abstract][Full Text] [Related]
23. A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer.
Lazzeroni M; Guerrieri-Gonzaga A; Gandini S; Johansson H; Serrano D; Cazzaniga M; Aristarco V; Macis D; Mora S; Caldarella P; Pagani G; Pruneri G; Riva A; Petrangolini G; Morazzoni P; DeCensi A; Bonanni B
Cancer Prev Res (Phila); 2017 Jun; 10(6):363-370. PubMed ID: 28400479
[TBL] [Abstract][Full Text] [Related]
24. Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers.
Misaka S; Abe O; Sato H; Ono T; Shikama Y; Onoue S; Yabe H; Kimura J
Eur J Clin Pharmacol; 2018 May; 74(5):601-609. PubMed ID: 29368187
[TBL] [Abstract][Full Text] [Related]
25. Cytochrome P450 3A4 and 2D6-mediated metabolism of leisure and medicinal teas.
Tam TW; Liu R; Saleem A; Arnason JT; Krantis A; Foster BC
J Pharm Pharm Sci; 2014; 17(3):294-301. PubMed ID: 25224344
[TBL] [Abstract][Full Text] [Related]
26. Effects of Khat (Catha edulis) use on catalytic activities of major drug-metabolizing cytochrome P450 enzymes and implication of pharmacogenetic variations.
Bedada W; de Andrés F; Engidawork E; Hussein J; LLerena A; Aklillu E
Sci Rep; 2018 Aug; 8(1):12726. PubMed ID: 30143732
[TBL] [Abstract][Full Text] [Related]
27. Effect of honey on CYP3A4, CYP2D6 and CYP2C19 enzyme activity in healthy human volunteers.
Tushar T; Vinod T; Rajan S; Shashindran C; Adithan C
Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):269-72. PubMed ID: 17371531
[TBL] [Abstract][Full Text] [Related]
28. Effect of commercial Rhodiola rosea on CYP enzyme activity in humans.
Thu OK; Spigset O; Nilsen OG; Hellum B
Eur J Clin Pharmacol; 2016 Mar; 72(3):295-300. PubMed ID: 26613955
[TBL] [Abstract][Full Text] [Related]
29. Effect of commercially available green and black tea beverages on drug-metabolizing enzymes and oxidative stress in Wistar rats.
Yao HT; Hsu YR; Lii CK; Lin AH; Chang KH; Yang HT
Food Chem Toxicol; 2014 Aug; 70():120-7. PubMed ID: 24815822
[TBL] [Abstract][Full Text] [Related]
30. Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study.
Derungs A; Donzelli M; Berger B; Noppen C; Krähenbühl S; Haschke M
Clin Pharmacokinet; 2016 Jan; 55(1):79-91. PubMed ID: 26123704
[TBL] [Abstract][Full Text] [Related]
31. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers.
Markowitz JS; Donovan JL; Devane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
Clin Pharmacol Ther; 2003 Dec; 74(6):536-42. PubMed ID: 14663456
[TBL] [Abstract][Full Text] [Related]
32. Plasma appearance and correlation between coffee and green tea metabolites in human subjects.
Renouf M; Guy P; Marmet C; Longet K; Fraering AL; Moulin J; Barron D; Dionisi F; Cavin C; Steiling H; Williamson G
Br J Nutr; 2010 Dec; 104(11):1635-40. PubMed ID: 20691128
[TBL] [Abstract][Full Text] [Related]
33. In vivo effects of interleukin-10 on human cytochrome P450 activity.
Gorski JC; Hall SD; Becker P; Affrime MB; Cutler DL; Haehner-Daniels B
Clin Pharmacol Ther; 2000 Jan; 67(1):32-43. PubMed ID: 10668851
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol.
Swaisland HC; Ranson M; Smith RP; Leadbetter J; Laight A; McKillop D; Wild MJ
Clin Pharmacokinet; 2005; 44(10):1067-81. PubMed ID: 16176119
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.
Chow HH; Garland LL; Hsu CH; Vining DR; Chew WM; Miller JA; Perloff M; Crowell JA; Alberts DS
Cancer Prev Res (Phila); 2010 Sep; 3(9):1168-75. PubMed ID: 20716633
[TBL] [Abstract][Full Text] [Related]
36. The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes.
Christensen M; Andersson K; Dalén P; Mirghani RA; Muirhead GJ; Nordmark A; Tybring G; Wahlberg A; Yaşar U; Bertilsson L
Clin Pharmacol Ther; 2003 Jun; 73(6):517-28. PubMed ID: 12811361
[TBL] [Abstract][Full Text] [Related]
37. Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers.
Abe O; Ono T; Sato H; Müller F; Ogata H; Miura I; Shikama Y; Yabe H; Onoue S; Fromm MF; Kimura J; Misaka S
Eur J Clin Pharmacol; 2018 Jun; 74(6):775-783. PubMed ID: 29480324
[TBL] [Abstract][Full Text] [Related]
38. In vivo modulation of CYP enzymes by quinidine and rifampin.
Branch RA; Adedoyin A; Frye RF; Wilson JW; Romkes M
Clin Pharmacol Ther; 2000 Oct; 68(4):401-11. PubMed ID: 11061580
[TBL] [Abstract][Full Text] [Related]
39. Characterization of human cytochrome P450 isoenzymes involved in the metabolism of vinorelbine.
Beulz-Riché D; Grudé P; Puozzo C; Sautel F; Filaquier C; Riché C; Ratanasavanh D
Fundam Clin Pharmacol; 2005 Oct; 19(5):545-53. PubMed ID: 16176333
[TBL] [Abstract][Full Text] [Related]
40. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
James KD; Forester SC; Lambert JD
Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
